BioSpace News Archive

BioMidwest

Washington University Completes Installation of Second MRIdian MR-Guided Radiotherapy System From ViewRay

This marks the hospital’s second MRIdian system, furthering their leadership role in the delivery of MR-guided radiation therapy.

November 10, 2017
·
3 min read
Business

Dyadic International Reports Third Quarter 2017 Financial Results

Management will host a conference call to discuss the financial results for the quarter ended September 30, 2017.

November 10, 2017
·
13 min read
Business

Alphatec Holdings Reports Third Quarter 2017 Financial Results

Total revenue of $23.1 million; U.S. commercial revenue of $20.7 million.

November 10, 2017
·
13 min read
Business

Caladrius Biosciences Reports 2017 Third Quarter Results

Conference call begins today at 4:30 p.m. Eastern Time.

November 10, 2017
·
10 min read
Biotech Bay

Molecular Devices Introduces pCLAMP 11 Electrophysiology Software

Among many new features, this latest version of the software includes intelligent data analysis capabilities as a part of the new Clampfit Advanced Analysis Module, allowing for improved automated event detection and batch analysis of data.

November 10, 2017
·
2 min read
Business

Omeros Reports Third Quarter 2017 Financial Results

Omeros today announced recent highlights and developments as well as financial results for the third quarter ended September 30, 2017, which include:

November 10, 2017
·
12 min read
Business

Skyline Medical Signs Distribution Agreement to Market STREAMWAY System in Australia and New Zealand

This distribution agreement is the latest milestone in our international expansion strategy, and follows the recent signing of partnerships with two independent distributors in Canada and Switzerland.

November 10, 2017
·
5 min read
Business

ICU Medical Announces Third Quarter 2017 Results

Third quarter 2017 revenue was $343.2 million, compared to $97.1 million in the same period last year.

November 10, 2017
·
21 min read
Business

Zomedica Pharmaceuticals Corp. Announces Third Quarter 2017 Financial Results

Zomedica recorded net loss and comprehensive loss for the three months ended September 30, 2017 of $2,080,682 or $0.02 per share.

November 10, 2017
·
8 min read
Business

AveXis Reports Third Quarter 2017 Financial and Operating Results

As of September 30, 2017, AveXis had $374.2 million in cash and cash equivalents.

November 10, 2017
·
13 min read